Chargement en cours...

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:RMD Open
Auteurs principaux: Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://ncbi.nlm.nih.gov/pubmed/26509061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000036
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!